Cargando…

miR-543 acts as a novel oncogene in oral squamous cell carcinoma by targeting CYP3A5

MicroRNAs (miRNAs/miRs) are small non-coding RNAs that can act as oncogenes or tumor-suppressor genes in human cancer. Previous studies have revealed that abnormal expression of miRNAs is closely associated with tumor cell cycle, differentiation, growth and apoptosis. miR-543 is expressed abnormally...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Liping, Chen, Weihong, Zha, Jun, Yan, Yongyong, Wei, Yongxiang, Chen, Xili, Zhu, Xinxin, Ge, Linhu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6667884/
https://www.ncbi.nlm.nih.gov/pubmed/31322243
http://dx.doi.org/10.3892/or.2019.7230
_version_ 1783440117640200192
author Wang, Liping
Chen, Weihong
Zha, Jun
Yan, Yongyong
Wei, Yongxiang
Chen, Xili
Zhu, Xinxin
Ge, Linhu
author_facet Wang, Liping
Chen, Weihong
Zha, Jun
Yan, Yongyong
Wei, Yongxiang
Chen, Xili
Zhu, Xinxin
Ge, Linhu
author_sort Wang, Liping
collection PubMed
description MicroRNAs (miRNAs/miRs) are small non-coding RNAs that can act as oncogenes or tumor-suppressor genes in human cancer. Previous studies have revealed that abnormal expression of miRNAs is closely associated with tumor cell cycle, differentiation, growth and apoptosis. miR-543 is expressed abnormally in a wide variety of cancers and has been associated with cellular proliferation, apoptosis, and invasion; however, the effect of miR-543 remains unknown in oral squamous cell carcinoma (OSCC). In the present study, the expression level of miR-543 in OSCC cell lines and tissues was investigated by RT-qPCR. A series of experiments was then performed to elucidate the functions of miR-543 in OSCC, such as CCK-8 assay, colony formation assay, flow cytometry, cell cycle distribution assay and cell apoptosis assay and Transwell assay. miR-543 expression was significantly upregulated in tumors from patients with OSCC and in OSCC cell lines. Overexpression of miR-543 promoted the proliferation, invasion and migration of OSCC cell lines, and inhibited cell apoptosis. In addition, the present study identified cytochrome P450 family 3 subfamily A member 5 (CYP3A5) as a direct target of miR-543 using software analysis and dual-luciferase reporter assays. In conclusion, the results of the present study suggest that miR-543 acts as a tumor promoter and serves a vital role in OSCC proliferation and invasion. These results confirm that miR-543 may serve as a potential novel target for the treatment of OSCC.
format Online
Article
Text
id pubmed-6667884
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher D.A. Spandidos
record_format MEDLINE/PubMed
spelling pubmed-66678842019-08-08 miR-543 acts as a novel oncogene in oral squamous cell carcinoma by targeting CYP3A5 Wang, Liping Chen, Weihong Zha, Jun Yan, Yongyong Wei, Yongxiang Chen, Xili Zhu, Xinxin Ge, Linhu Oncol Rep Articles MicroRNAs (miRNAs/miRs) are small non-coding RNAs that can act as oncogenes or tumor-suppressor genes in human cancer. Previous studies have revealed that abnormal expression of miRNAs is closely associated with tumor cell cycle, differentiation, growth and apoptosis. miR-543 is expressed abnormally in a wide variety of cancers and has been associated with cellular proliferation, apoptosis, and invasion; however, the effect of miR-543 remains unknown in oral squamous cell carcinoma (OSCC). In the present study, the expression level of miR-543 in OSCC cell lines and tissues was investigated by RT-qPCR. A series of experiments was then performed to elucidate the functions of miR-543 in OSCC, such as CCK-8 assay, colony formation assay, flow cytometry, cell cycle distribution assay and cell apoptosis assay and Transwell assay. miR-543 expression was significantly upregulated in tumors from patients with OSCC and in OSCC cell lines. Overexpression of miR-543 promoted the proliferation, invasion and migration of OSCC cell lines, and inhibited cell apoptosis. In addition, the present study identified cytochrome P450 family 3 subfamily A member 5 (CYP3A5) as a direct target of miR-543 using software analysis and dual-luciferase reporter assays. In conclusion, the results of the present study suggest that miR-543 acts as a tumor promoter and serves a vital role in OSCC proliferation and invasion. These results confirm that miR-543 may serve as a potential novel target for the treatment of OSCC. D.A. Spandidos 2019-09 2019-07-11 /pmc/articles/PMC6667884/ /pubmed/31322243 http://dx.doi.org/10.3892/or.2019.7230 Text en Copyright: © Wang et al. This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License (https://creativecommons.org/licenses/by-nc-nd/4.0/) , which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.
spellingShingle Articles
Wang, Liping
Chen, Weihong
Zha, Jun
Yan, Yongyong
Wei, Yongxiang
Chen, Xili
Zhu, Xinxin
Ge, Linhu
miR-543 acts as a novel oncogene in oral squamous cell carcinoma by targeting CYP3A5
title miR-543 acts as a novel oncogene in oral squamous cell carcinoma by targeting CYP3A5
title_full miR-543 acts as a novel oncogene in oral squamous cell carcinoma by targeting CYP3A5
title_fullStr miR-543 acts as a novel oncogene in oral squamous cell carcinoma by targeting CYP3A5
title_full_unstemmed miR-543 acts as a novel oncogene in oral squamous cell carcinoma by targeting CYP3A5
title_short miR-543 acts as a novel oncogene in oral squamous cell carcinoma by targeting CYP3A5
title_sort mir-543 acts as a novel oncogene in oral squamous cell carcinoma by targeting cyp3a5
topic Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6667884/
https://www.ncbi.nlm.nih.gov/pubmed/31322243
http://dx.doi.org/10.3892/or.2019.7230
work_keys_str_mv AT wangliping mir543actsasanoveloncogeneinoralsquamouscellcarcinomabytargetingcyp3a5
AT chenweihong mir543actsasanoveloncogeneinoralsquamouscellcarcinomabytargetingcyp3a5
AT zhajun mir543actsasanoveloncogeneinoralsquamouscellcarcinomabytargetingcyp3a5
AT yanyongyong mir543actsasanoveloncogeneinoralsquamouscellcarcinomabytargetingcyp3a5
AT weiyongxiang mir543actsasanoveloncogeneinoralsquamouscellcarcinomabytargetingcyp3a5
AT chenxili mir543actsasanoveloncogeneinoralsquamouscellcarcinomabytargetingcyp3a5
AT zhuxinxin mir543actsasanoveloncogeneinoralsquamouscellcarcinomabytargetingcyp3a5
AT gelinhu mir543actsasanoveloncogeneinoralsquamouscellcarcinomabytargetingcyp3a5